Panagora Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,480
| Closed | -$130K | – | 2626 |
|
|
2019
Q4 | $130K | Hold |
1,480
| – | – | ﹤0.01% | 1738 |
|
|
2019
Q3 | $112K | Hold |
1,480
| – | – | ﹤0.01% | 1797 |
|
|
2019
Q2 | $126K | Hold |
1,480
| – | – | ﹤0.01% | 1911 |
|
|
2019
Q1 | $160K | Hold |
1,480
| – | – | ﹤0.01% | 1772 |
|
|
2018
Q4 | $125K | Hold |
1,480
| – | – | ﹤0.01% | 1766 |
|
|
2018
Q3 | $145K | Hold |
1,480
| – | – | ﹤0.01% | 1765 |
|
|
2018
Q2 | $171K | Hold |
1,480
| – | – | ﹤0.01% | 1708 |
|
|
2018
Q1 | $146K | Hold |
1,480
| – | – | ﹤0.01% | 1761 |
|
|
2017
Q4 | $155K | Sell |
1,480
-44,567
| -97% | -$4.67M | ﹤0.01% | 1749 |
|
|
2017
Q3 | $5.19M | Buy |
46,047
+4,711
| +11% | +$531K | 0.02% | 563 |
|
|
2017
Q2 | $4.63M | Buy |
41,336
+5,303
| +15% | +$594K | 0.02% | 598 |
|
|
2017
Q1 | $4.2M | Sell |
36,033
-182
| -0.5% | -$21.2K | 0.02% | 634 |
|
|
2016
Q4 | $3.81M | Sell |
36,215
-5,581
| -13% | -$587K | 0.02% | 641 |
|
|
2016
Q3 | $4.62M | Sell |
41,796
-28,038
| -40% | -$3.1M | 0.02% | 573 |
|
|
2016
Q2 | $10.2M | Buy |
69,834
+5,908
| +9% | +$860K | 0.05% | 368 |
|
|
2016
Q1 | $9.16M | Buy |
63,926
+22,713
| +55% | +$3.25M | 0.05% | 387 |
|
|
2015
Q4 | $6.37M | Buy |
41,213
+23,322
| +130% | +$3.6M | 0.03% | 482 |
|
|
2015
Q3 | $2.55M | Buy |
17,891
+4,717
| +36% | +$673K | 0.01% | 691 |
|
|
2015
Q2 | $1.89M | Buy |
13,174
+989
| +8% | +$142K | 0.01% | 825 |
|
|
2015
Q1 | $1.72M | Buy |
12,185
+2,133
| +21% | +$301K | 0.01% | 834 |
|
|
2014
Q4 | $1.49M | Buy |
10,052
+9,341
| +1,314% | +$1.38M | 0.01% | 855 |
|
|
2014
Q3 | $109K | Buy |
+711
| New | +$109K | ﹤0.01% | 1838 |
|